Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY - Hehlmann, Rüdiger (American journal of hematology, 2019)
First published: 05 October 2018